These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 34677365)
41. Salivary biomarkers for detection of oral squamous cell carcinoma - current state and recent advances. Yakob M; Fuentes L; Wang MB; Abemayor E; Wong DT Curr Oral Health Rep; 2014 Jun; 1(2):133-141. PubMed ID: 24883261 [TBL] [Abstract][Full Text] [Related]
42. Discovery and preclinical validation of proteomic biomarkers in saliva for early detection of oral squamous cell carcinomas. Shan J; Sun Z; Yang J; Xu J; Shi W; Wu Y; Fan Y; Li H Oral Dis; 2019 Jan; 25(1):97-107. PubMed ID: 30169911 [TBL] [Abstract][Full Text] [Related]
43. Oral squamous cell carcinoma detection by salivary biomarkers in a Serbian population. Brinkmann O; Kastratovic DA; Dimitrijevic MV; Konstantinovic VS; Jelovac DB; Antic J; Nesic VS; Markovic SZ; Martinovic ZR; Akin D; Spielmann N; Zhou H; Wong DT Oral Oncol; 2011 Jan; 47(1):51-5. PubMed ID: 21109482 [TBL] [Abstract][Full Text] [Related]
44. Chronic periodontitis can affect the levels of potential oral cancer salivary mRNA biomarkers. Cheng YL; Jordan L; Chen HS; Kang D; Oxford L; Plemons J; Parks H; Rees T J Periodontal Res; 2017 Jun; 52(3):428-437. PubMed ID: 27549383 [TBL] [Abstract][Full Text] [Related]
45. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma. G D; Nandan SRK; Kulkarni PG Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970 [TBL] [Abstract][Full Text] [Related]
46. Saliva protein biomarkers to detect oral squamous cell carcinoma in a high-risk population in Taiwan. Yu JS; Chen YT; Chiang WF; Hsiao YC; Chu LJ; See LC; Wu CS; Tu HT; Chen HW; Chen CC; Liao WC; Chang YT; Wu CC; Lin CY; Liu SY; Chiou ST; Chia SL; Chang KP; Chien CY; Chang SW; Chang CJ; Young JD; Pao CC; Chang YS; Hartwell LH Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11549-11554. PubMed ID: 27663741 [TBL] [Abstract][Full Text] [Related]
47. Proteomic Profiling of Paired Interstitial Fluids Reveals Dysregulated Pathways and Salivary NID1 as a Biomarker of Oral Cavity Squamous Cell Carcinoma. Hsu CW; Chang KP; Huang Y; Liu HP; Hsueh PC; Gu PW; Yen WC; Wu CC Mol Cell Proteomics; 2019 Oct; 18(10):1939-1949. PubMed ID: 31315917 [TBL] [Abstract][Full Text] [Related]
48. Exploring a Novel Screening Method for Patients with Oral Squamous Cell Carcinoma: A plasma Metabolomics Analysis. Enomoto Y; Kimoto A; Suzuki H; Nishiumi S; Yoshida M; Komori T Kobe J Med Sci; 2018 Sep; 64(1):E26-E35. PubMed ID: 30282895 [TBL] [Abstract][Full Text] [Related]
49. Salivary proteome profiling of oral squamous cell carcinoma in a Hungarian population. Csősz É; Márkus B; Darula Z; Medzihradszky KF; Nemes J; Szabó E; Tőzsér J; Kiss C; Márton I FEBS Open Bio; 2018 Apr; 8(4):556-569. PubMed ID: 29632809 [TBL] [Abstract][Full Text] [Related]
50. Salivary transcriptome diagnostics for oral cancer detection. Li Y; St John MA; Zhou X; Kim Y; Sinha U; Jordan RC; Eisele D; Abemayor E; Elashoff D; Park NH; Wong DT Clin Cancer Res; 2004 Dec; 10(24):8442-50. PubMed ID: 15623624 [TBL] [Abstract][Full Text] [Related]
51. Proteomics investigation of OSCC-specific salivary biomarkers in a Hungarian population highlights the importance of identification of population-tailored biomarkers. Csősz É; Lábiscsák P; Kalló G; Márkus B; Emri M; Szabó A; Tar I; Tőzsér J; Kiss C; Márton I PLoS One; 2017; 12(5):e0177282. PubMed ID: 28545132 [TBL] [Abstract][Full Text] [Related]
52. Correlation of Cyfra 21-1 levels in saliva and serum with CK19 mRNA expression in oral squamous cell carcinoma. Malhotra R; Urs AB; Chakravarti A; Kumar S; Gupta VK; Mahajan B Tumour Biol; 2016 Jul; 37(7):9263-71. PubMed ID: 26779624 [TBL] [Abstract][Full Text] [Related]
53. Oral Health May Affect the Performance of mRNA-Based Saliva Biomarkers for Oral Squamous Cell Cancer. Horváth J; Szabó A; Tar I; Dezső B; Kiss C; Márton I; Scholtz B Pathol Oncol Res; 2018 Oct; 24(4):833-842. PubMed ID: 28861772 [TBL] [Abstract][Full Text] [Related]
54. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform. Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828 [TBL] [Abstract][Full Text] [Related]
55. Serum metabolomics in oral leukoplakia and oral squamous cell carcinoma. Sridharan G; Ramani P; Patankar S J Cancer Res Ther; 2017; 13(3):556-561. PubMed ID: 28862226 [TBL] [Abstract][Full Text] [Related]
56. Salivary auto-antibodies as noninvasive diagnostic markers of oral cavity squamous cell carcinoma. Wu CC; Chang YT; Chang KP; Liu YL; Liu HP; Lee IL; Yu JS; Chiang WF Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1569-78. PubMed ID: 24859869 [TBL] [Abstract][Full Text] [Related]
57. Salivary and serum level of CYFRA 21-1 in oral precancer and oral squamous cell carcinoma. Rajkumar K; Ramya R; Nandhini G; Rajashree P; Ramesh Kumar A; Nirmala Anandan S Oral Dis; 2015 Jan; 21(1):90-6. PubMed ID: 24304502 [TBL] [Abstract][Full Text] [Related]
58. Verification of Saliva Matrix Metalloproteinase-1 as a Strong Diagnostic Marker of Oral Cavity Cancer. Chang YT; Chu LJ; Liu YC; Chen CJ; Wu SF; Chen CH; Chang IY; Wang JS; Wu TY; Dash S; Chiang WF; Chiu SF; Gou SB; Chien CY; Chang KP; Yu JS Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32823758 [TBL] [Abstract][Full Text] [Related]